Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Viking Thera (VKTX)

Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,595,043
  • Shares Outstanding, K 112,310
  • Annual Sales, $ 0 K
  • Annual Income, $ -109,960 K
  • EBIT $ -172 M
  • EBITDA $ -189 M
  • 60-Month Beta 0.62
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.25

Options Overview Details

View History
  • Implied Volatility 143.60% ( +8.91%)
  • Historical Volatility 58.79%
  • IV Percentile 99%
  • IV Rank 99.76%
  • IV High 143.81% on 07/08/25
  • IV Low 60.62% on 06/03/25
  • Put/Call Vol Ratio 0.19
  • Today's Volume 25,471
  • Volume Avg (30-Day) 18,409
  • Put/Call OI Ratio 0.28
  • Today's Open Interest 237,133
  • Open Int (30-Day) 222,353

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.44
  • Number of Estimates 11
  • High Estimate -0.37
  • Low Estimate -0.54
  • Prior Year -0.20
  • Growth Rate Est. (year over year) -120.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.80 +34.50%
on 06/23/25
33.16 -3.47%
on 07/18/25
+5.73 (+21.80%)
since 06/18/25
3-Month
23.30 +37.38%
on 04/21/25
33.16 -3.47%
on 07/18/25
+8.07 (+33.71%)
since 04/17/25
52-Week
18.92 +69.19%
on 04/09/25
81.73 -60.83%
on 10/28/24
-18.09 (-36.11%)
since 07/18/24

Most Recent Stories

More News
Viking Therapeutics to Report Financial Results for Second Quarter 2025 on July 23, 2025

  Conference Call Scheduled for Wednesday, July 23 at 4:30 p.m. Eastern Time           

VKTX : 32.01 (-0.19%)
Better Growth Buy: Eli Lilly vs. Viking Therapeutics

VKTX : 32.01 (-0.19%)
NVO : 64.31 (-1.50%)
LLY : 771.71 (+1.34%)
GS : 708.26 (+0.34%)
Why I Think Viking Therapeutics Is an Asymmetric Growth Opportunity

VKTX : 32.01 (-0.19%)
2 Beaten-Down Stocks With Massive Upside Potential

VKTX : 32.01 (-0.19%)
CRSP : 65.13 (+18.22%)
10 Incredible Growth Stocks Poised for Long-Term Gains

VKTX : 32.01 (-0.19%)
ACHR : 13.29 (-0.82%)
NVTS : 6.79 (+8.29%)
OSCR : 13.42 (-3.24%)
BBAI : 7.95 (-3.28%)
RKLB : 51.39 (+0.12%)
EQIX : 777.78 (+0.28%)
JOBY : 17.78 (+0.34%)
LUNR : 12.41 (+1.31%)
PLTR : 153.52 (-0.31%)
Got $200? 2 Biotech Stocks to Buy and Hold Forever

VKTX : 32.01 (-0.19%)
NVO : 64.31 (-1.50%)
LLY : 771.71 (+1.34%)
MRNA : 31.26 (-2.92%)
3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking

Timing matters with biotech stocks; these three companies offer distinct risk-reward profiles but have upcoming catalysts that could redefine their value

VKTX : 32.01 (-0.19%)
IOVA : 2.23 (-4.70%)
NVO : 64.31 (-1.50%)
NBIX : 132.02 (-1.56%)
LLY : 771.71 (+1.34%)
Why This Weight Loss Drug Company's Stock Surged Today

VKTX : 32.01 (-0.19%)
3 Growth Stocks I'm Loading Up On

VKTX : 32.01 (-0.19%)
APLD : 11.93 (+9.35%)
PLTR : 153.52 (-0.31%)
My 5 Favorite Dirt Cheap Stocks to Buy Right Now

TGT : 103.46 (-0.18%)
GOOG : 185.94 (+0.67%)
GOOGL : 185.06 (+0.81%)
VKTX : 32.01 (-0.19%)
CUK : 26.94 (+0.41%)
CCL : 29.55 (+0.34%)
PFE : 24.47 (-0.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Average short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Viking Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in development of novel therapies for metabolic and endocrine disorders. Its product candidate consists of VK5211, VK0214, VK0612 and VK2809 which are in different clinical trial. Viking Therapeutics, Inc. is based in LA...

See More

Key Turning Points

3rd Resistance Point 34.91
2nd Resistance Point 34.03
1st Resistance Point 33.02
Last Price 32.01
1st Support Level 31.14
2nd Support Level 30.26
3rd Support Level 29.25

See More

52-Week High 81.73
Fibonacci 61.8% 57.74
Fibonacci 50% 50.32
Fibonacci 38.2% 42.91
Last Price 32.01
52-Week Low 18.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar